期刊文献+

重症感染患者病情严重程度对抗菌药物表观分布容积的影响 被引量:6

The analysis of the influence of severe infection on the apparent volume of distribution of antibacterial drugs
原文传递
导出
摘要 重症感染是威胁重症患者生命的常见病,早期合理使用抗菌药物是重症感染治疗的关键环节.重症患者特殊的病理生理状态影响抗菌药物药代动力学(PK),其中以表观分布容积(Vd)变化显著,这使药效学的达标率显著降低.多种因素可影响抗菌药物在重症患者体内的分布,如病情严重程度、器官功能障碍、组织水肿以及药物的亲水性等,且这些因素常常可能会同时存在.本文就重症患者病情严重程度对抗菌药物Vd的影响作一综述. Sepsis is a major cause of mortality in intensive care unit (ICU). Early and correct antibacterial coverage is essential. But the pharmacokinetics (PK) of antibiotics can be compromised as a result of altered physiology in the critically ill patients. The apparent volume of distribution (Vd) is an important PK parameter and can determine the loading dose. This review article summarizes the key changes in Vd of antibiotic in patients with severe infection, and provides general suggestions on optimization of antibiotic dosing to deal with Vd challenges.
作者 杨洁 黄英姿 Yang Jie;Huang Yingzi(Department of Critical Care Medicine,Zhongda Hospital,School of Medicine,Southeast University,Nanjing 210009,China)
出处 《中华重症医学电子杂志》 2019年第3期282-285,共4页 Chinese Journal Of Critical Care & Intensive Care Medicine(Electronic Edition)
基金 南京药学会——常州四药医院药学科研基金(2015YX004)
关键词 重症感染 抗菌药物 表观分布容积 药代动力学 Sepsis Antibacterial drugs Apparent volume of distribution Pharmacokinetic
  • 相关文献

参考文献1

二级参考文献21

  • 1Kaukonen KM, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012 [ J ]. JAMA, 2014,311 (13) :1308-1316.
  • 2Taccone FS, Laterre PF, Dugernier T, et al. Insufficient 13- laetam concentrations in the early phase of severe sepsis and septic shock[J]. Crit Care,2010,14(4) :R126.
  • 3Roberts JA, Paul SK, Akova M, et, al. DALI : defining antibiotic levels in intensive care unit patients: are current 13-1actam antibiotic doses sufficient for critically ill patients? [ J ]. Clin Infect Dis, 2014, 58(8):1072-1083.
  • 4Roberts JA, Abdul-Aziz MH, Lipman J, et al. Individualised antibiotic dosing for patients who are critically ill:challenges and potential solutions[J]. Lancet Infect Dis, 2014,14(6) :498-509.
  • 5Ulldemnlins M, Roberts JA, Lipman J, et al. Antibiotic dosing in muhiple organ dysfunction syndrome [ J ]. Chest, 2011,139 ( 5 ) : 1210-1220.
  • 6Ulldemolins M, Rello J. The relevance of drug volume of distribution in antibiotic dosing [ J ]. CmT Pharm Biotechnol, 2011,12(12) :1996-2001.
  • 7SAFE Study Investigatorsl, Finfer S, Bellomo R, et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units:analysis of data from the saline versus albumin fluid evaluation ( SAFE ) study[J]. BMJ, 2006, 333(7577):1044.
  • 8Marik PE. Aminoglycoside volume of distribution and illness severity in critically ill septic patients [ J ]. Anaesth Intensive Care, 1993,21(2) :172-173.
  • 9Ulldemolins M, Roberts JA, Lipman J, et al. Antibiotic dosing in multiple organ dysfunction syndrome [ J ]. Chest, 2011,139 (5) : 1210-1220.
  • 10Ulldemolins M, Roberts JA, Rello J, et al. The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients[ J]. Clin Pharmacokinet, 2011,50(2) :99-110.

共引文献25

同被引文献44

引证文献6

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部